Latest Breaking News On - Ray neag comprehensive cancer - Page 1 : comparemela.com

Tackling the Aspartame Argument with a UConn Health Expert

Natalie Ranelli, registered dietitian in UConn Health’s Neag Comprehensive Cancer Center, weighs in on synthetic sweetener’s safety

Battling Stage 4 Breast Cancer for 4 Years: 'I Have Cancer, But Cancer Does Not Have Me'

A Multidisciplinary Approach to Surviving Head and Neck Cancer

Date Time A Multidisciplinary Approach to Surviving Head and Neck Cancer Treatment of advanced head and neck cancer requires close collaborations between several health care services. The team at the Carole and Ray Neag Comprehensive Cancer Center provides a multidisciplinary approach that provides better outcomes. The UConn Heath multi-disciplinary head and neck cancer team. On the first morning of Tiffany Patchell’s visit with her dad in Texas in late 2018, she awoke with what felt like a horrible ear infection. Upon returning to Connecticut several days later she visited an urgent care clinic where she was diagnosed with an ear infection and prescribed antibiotics. Her ear continued to bother her and she followed up every few months at the urgent care. The pain then started to extend from her right ear to the right side of her throat and she couldn’t swallow without feeling pain or burning.

Meet the Researcher: Jayesh Kamath, School of Medicine

Meet the Researcher: Jayesh Kamath, School of Medicine Jayesh Kamath is bringing psychiatry into the mobile tech era by using mHealth technologies to support patients with depression Jayesh Kamath in his office (Contributed photo) Copy Link Dr. Jayesh Kamath sees psychiatry differently. By nature of the field, psychiatry has not been able to take advantage of the objective tools and tests available to other medical fields. Kamath, UConn Health professor of psychiatry and immunology, however, sees the potential for mobile health (mHealth) technologies to support psychiatrists, as well as the critical connections between mental and physical health for cancer patients.

Utilizing Pharmacogenomics Information to Guide AML Treatment